JPRN-C000000179已完成3 期
Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) - Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 450 人开始时间: 2005年9月12日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •I. pregnant II. malignant pleural effusion, ascites, or pericardial effusion that requires emergent treatment III. Active infection IV. other cancer present within the last 5 years V. previous stem cell transplantation VI. brain metastasis that requires emergent treatment VII. relapse within 6 months after completion anthracycline or during anthracycline VIII. more than 250mg/m2 of anthracyclines IX. hypersensitivitiy of drug X. interstitial pneumonitis or pulmonary fibrosis XI. positive HBs XII. antipsychotic medication XIII. doctor's judgement
研究者
相似试验
已完成
3 期
Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102)Patients with cervical cancerJPRN-C000000194Japan Clinical Oncology Group(JCOG)200
已完成
3 期
Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)Stage III colorectal cancerJPRN-C000000193Japan Clinical Oncology Group(JCOG)1,100
已完成
3 期
A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)uterine cervical neoplasmsJPRN-C000000335Japan Clinical Oncology Group(JCOG)250
已完成
3 期
A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)extensive-disease small cell lung cancerJPRN-UMIN000000720Japan Clinical Oncology Group(JCOG)282
已完成
3 期
Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)on-Hodgkin's lymphomaJPRN-C000000036Japan Clinical Oncology Group(JCOG)450